Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 16, 1998

View Archived Issues

Elan 'Replenishes Coffers' With US$750M Placement

New Cervical Smear Test Proves Superior In Studies

Celltech Says Data Positive In Pivotal Leukemia Study

OGS, Quintiles Team Up In Proteomics Agreement

Amrad Wins A$24.6M Grant For R&D From Government

Vaxis Aims For Share Of Impotence Market

Start-Up Wilex Targeting Tumor-Metastasis Enzymes

BioChem, SmithKline Sign Deal For Nasal Flu Vaccine

Teva Likely To Appeal Court's Fluoxetine Ruling

Vanguard Quits Dialysis Drug, Pairs With 3M For Hepatitis C

GPC, Byk Gulden Enter Deal For Genomic Targets

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...